Discussion Here, we report that the acute physiological and subjective effects of alcohol differ in people with obesity taking a GLP-1RA from people with obesity not on a GLP-1RA medication
Finally, to gain initial insight regarding the interaction site for TBC1D9B within TMEM55B, we examined the AlphaFold2 model of TMEM55B (Supplementary Fig
Food & Drug Administration (FDA) determined that the shortage of the tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, has been resolved and removed from the FDAs shortage list, see our prior blog GLP-1 Drugs: FDA Removes Lillys Zepbound and Mounjaro (tirzepatide injection) from its Drug Shortage List, on October 8, 2024, the Outsourcing Facilities Association (OFA) a trade association representing FDA-registered 503B outsourcing facilities filed a lawsuit against the FDA relating to the agencys removal of tirzepatide, from the FDAs drug shortage list
Ellagic acid protects against diabetes-associated behavioral deficits in rats: possible involved mechanisms
That's the idea behind it anyway